U.S. Stem Cell, Inc. Quarterly Debt-to-equity in % from Q1 2016 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
U.S. Stem Cell, Inc. quarterly Debt-to-equity history and growth rate from Q1 2016 to Q4 2022.
  • U.S. Stem Cell, Inc. Debt-to-equity for the quarter ending December 31, 2022 was -101 %, a 1.19% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 -101 +1.21 +1.19% Dec 31, 2022
Q3 2022 -101 +1.35 +1.32% Sep 30, 2022
Q2 2022 -101 +1.63 +1.59% Jun 30, 2022
Q1 2022 -101 +1.45 +1.42% Mar 31, 2022
Q4 2021 -102 -0.84 -0.83% Dec 31, 2021
Q3 2021 -102 -0.91 -0.9% Sep 30, 2021
Q2 2021 -102 +0.42 +0.41% Jun 30, 2021
Q1 2021 -102 +2.38 +2.27% Mar 31, 2021
Q4 2020 -101 +7.45 +6.86% Dec 31, 2020
Q3 2020 -101 +13.7 +11.9% Sep 30, 2020
Q2 2020 -103 +18.3 +15.1% Jun 30, 2020
Q1 2020 -105 +21.4 +17% Mar 31, 2020
Q4 2019 -109 +22.4 +17.1% Dec 31, 2019
Q3 2019 -115 +15 +11.5% Sep 30, 2019
Q2 2019 -121 +7.16 +5.59% Jun 30, 2019
Q1 2019 -126 -0.18 -0.14% Mar 31, 2019
Q4 2018 -131 -9.43 -7.76% Dec 31, 2018
Q3 2018 -130 -12.9 -11% Sep 30, 2018
Q2 2018 -128 -15.8 -14.1% Jun 30, 2018
Q1 2018 -126 -18.1 -16.8% Mar 31, 2018
Q4 2017 -122 -16.7 -15.9% Dec 31, 2017
Q3 2017 -117 -12.8 -12.2% Sep 30, 2017
Q2 2017 -112 -8.48 -8.17% Jun 30, 2017
Q1 2017 -108 -4.25 -4.1% Mar 31, 2017
Q4 2016 -105 Dec 31, 2016
Q3 2016 -104 Sep 30, 2016
Q2 2016 -104 Jun 30, 2016
Q1 2016 -104 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.